Skip to main content

CORRECTION article

Front. Oncol., 19 April 2023
Sec. Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1170066

Corrigendum: Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients

This article is a correction to:

  1. Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients

    1. Read original article
Ping Chen&#x;Ping Chen1†Haolin Song&#x;Haolin Song2†Wei Xu&#x;Wei Xu3†Jin GuoJin Guo4Jianfei WangJianfei Wang5Juhong ZhouJuhong Zhou5Xiang KangXiang Kang5Chaolei JinChaolei Jin6Yubo Cai,,Yubo Cai7,8,9Zixuan FengZixuan Feng4Hainv GaoHainv Gao1Fengmin Lu,*Fengmin Lu10,11*Lanjuan Li,,*Lanjuan Li7,8,9*
  • 1Department of Infectious Diseases, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, China
  • 2College of Medicine, Zhejiang University, Hangzhou, China
  • 3College of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China
  • 4Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China
  • 5Research and Development Division, Oriomics Biotech Inc, Hangzhou, China
  • 6Infection and Immunity Institute and Translational Medical Center of Huaihe Hospital, Henan University, Kaifeng, China
  • 7State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
  • 8National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
  • 9Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
  • 10Department of Microbiology & Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China
  • 11Hepatology Institute, Peking University People’s Hospital, Beijing, China

A corrigendum on
Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients

by Chen P, Song H, Xu W, Guo J, Wang J, Zhou J, Kang X, Jin C, Cai Y, Feng Z, Gao H, Lu F, Li L (2022) Front. Oncol. 12:1037742. doi: 10.3389/fonc.2022.1037742

Error in author list

In the published article, there was an error in the author list. The corrected author list appears below.

Ping Chen 1†, Haolin Song 2†, Wei Xu 3†, Jin Guo4, Jianfei Wang5, Juhong Zhou5, Xiang Kang5, Chaolei Jin6, Yubo Cai7,8,9, Zixuan Feng4, Hainv Gao1, Fengmin Lu10,11*, Lanjuan Li7,8,9*

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Incorrect affiliation

In the published article, there was an error in affiliation(s). Instead of

1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China,

2National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China,

3Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China,

4Department of Microbiology & Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China,

5Hepatology Institute, Peking University People’s Hospital, Beijing, China,

6Department of Infectious Diseases, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, China,

7College of Medicine, Zhejiang University, Hangzhou, China,

8College of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China,

9Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China,

10Research and Development Division, Oriomics Biotech Inc, Hangzhou, China,

11Infection and Immunity Institute and Translational Medical Center of Huaihe Hospital, Henan University, Kaifeng, China,

it should be

1Department of Infectious Diseases, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, China,

2College of Medicine, Zhejiang University, Hangzhou, China,

3College of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China,

4Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China,

5Research and Development Division, Oriomics Biotech Inc, Hangzhou, China,

6Infection and Immunity Institute and Translational Medical Center of Huaihe Hospital, Henan University, Kaifeng, China,

7State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China,

8National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China,

9Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China,

10Department of Microbiology & Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China,

11Hepatology Institute, Peking University People’s Hospital, Beijing, China

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: hepatocellular carcinoma, alpha-fetoprotein, DCP, GALAD, GAADPB

Citation: Chen P, Song H, Xu W, Guo J, Wang J, Zhou J, Kang X, Jin C, Cai Y, Feng Z, Gao H, Lu F and Li L (2023) Corrigendum: Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients. Front. Oncol. 13:1170066. doi: 10.3389/fonc.2023.1170066

Received: 20 February 2023; Accepted: 21 February 2023;
Published: 19 April 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Chen, Song, Xu, Guo, Wang, Zhou, Kang, Jin, Cai, Feng, Gao, Lu and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Fengmin Lu, lu.fengmin@hsc.pku.edu.cn; Lanjuan Li, ljli@zju.edu.cn

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.